J&J Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine

J&J announced its Janssen Pharma Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen’s SARS...

Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine

Sanofi and GSK are in advanced discussions, with the EC for the supply of up to 300 million doses of a COVID-19 vaccine. The vaccine candidate developed by Sanofi in partnership with GSK...

Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate

Pfizer Inc and BioNTech SE announced an agreement with the Ministry of Health, Labour and Welfare in Japan to supply 120 million doses of BNT162 mRNA-based vaccine candidate against SARS-CoV2...

Lupin Launches Favipiravir Drug Covihalt for Treatment of Mild to Moderate COVID-19

Pharma major Lupin Limited announced the launch of its Favipiravir in India under the brand name Covihalt for the treatment of mild to moderate COVID-19. Favipiravir has received authorization...

Zydus Cadila announces completion of dosing in Phase I clinical trial of ZyCoV-D

Zydus Cadila company focused on discovering and developing NCEs, Novel Biologicals, Biosimilars and Vaccines, announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was found to be safe...

Members of the COVID R&D Alliance and Quantum Leap Healthcare Collaborative Enroll First Patients in I-SPY COVID Trial

Members of the COVID R&D Alliance AbbVie, Inc., Amgen Inc., and Takeda Pharmaceutical Co. Ltd. announced the first patients enrolled in the I-SPY COVID Trial clinical trial.

YoSync Collaborates with IIIT Bangalore to Launch India's First-Ever COVID-19 Blockchain Platform, BelYo

YoSync signed a research collaboration in agreement with IIIT Bangalore, to partner with BelfricsBT, a Malaysian based blockchain startup.

Over 300 Clinical Studies Benefit from CluePoints COVID-19 Risk Management Support

CluePoints announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trials.

Novartis Cosentyx receives EU approval for first line systemic treatment in pediatric psoriasis

Novarti announced the EC has granted the approval for Cosentyx for the treatment of moderate to severe plaque psoriasis in children and adolescents aged 6 to <18 years.

Cryoport Partners with Medical holding to Bring Temp Controlled Supply Chain Solutions to the Japanese Market

Cryoport and Medical holding, Japan's leading pharma wholesaler and distributor announced a multi-year strategic business alliance agreement to create an integrated regenerative..

Pharmapack Moves to May 2021

Pharmapack Europe, organised by Informa Markets, moves to May 2021 (19-20) to provide attendees, exhibitors and the pharma packaging community the best season and format.